Gastrointestinal complications: the most frequent internal complications of systemic sclerosis
- PMID: 19487222
- DOI: 10.1093/rheumatology/ken485
Gastrointestinal complications: the most frequent internal complications of systemic sclerosis
Abstract
Manifestations of SSc in the gastrointestinal (GI) tract are common, occurring in 50-90% of patients. They typically result from the fibrosis that characterizes this disease. Manifestations of SSc can affect many sites within the GI tract, and patients may experience substantial dysfunction in the processes of motility, digestion, absorption and excretion. Oesophageal dysfunction is the most common GI manifestation, but patients may also experience dysfunction of the stomach, small intestine, colon and rectum, each of which can be responsible for severe and distressing symptoms. At present, few specific therapeutic options are available for the treatment of these patients, but relief of symptoms is often possible with appropriate knowledge and support. It is therefore particularly important to identify, monitor and manage these patients carefully, with a view to minimizing further degeneration and maximizing quality of life.
Similar articles
-
["Pulmonary hypertension" of the gastrointestinal tract in patients with systemic sclerosis: thoughts on a not (yet) existing disease entity].Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S203-5. doi: 10.1055/s-0028-1091239. Epub 2008 Sep 23. Dtsch Med Wochenschr. 2008. PMID: 18814097 Review. German.
-
Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.Semin Arthritis Rheum. 2006 Dec;36(3):173-81. doi: 10.1016/j.semarthrit.2006.08.002. Epub 2006 Oct 11. Semin Arthritis Rheum. 2006. PMID: 17045629 Review.
-
Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.Semin Arthritis Rheum. 2005 Feb;34(4):689-702. doi: 10.1016/j.semarthrit.2004.08.009. Semin Arthritis Rheum. 2005. PMID: 15692963 Review.
-
Gastrointestinal motility disorder assessment in systemic sclerosis.Rheumatology (Oxford). 2013 Jun;52(6):1095-100. doi: 10.1093/rheumatology/kes429. Epub 2013 Feb 4. Rheumatology (Oxford). 2013. PMID: 23382360
-
Gastrointestinal manifestation of systemic sclerosis--thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign.Rheumatology (Oxford). 2010 Feb;49(2):368-72. doi: 10.1093/rheumatology/kep381. Epub 2009 Dec 14. Rheumatology (Oxford). 2010. PMID: 20008473
Cited by
-
Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis.Clin Exp Med. 2024 Sep 19;24(1):225. doi: 10.1007/s10238-024-01466-1. Clin Exp Med. 2024. PMID: 39294494 Free PMC article.
-
Complex Gastroesophageal Reflux Disease.Gastro Hep Adv. 2022 Apr 5;1(3):420-430. doi: 10.1016/j.gastha.2022.02.014. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131678 Free PMC article. Review.
-
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease.Lancet Rheumatol. 2022 Nov;4(11):e795-e803. doi: 10.1016/S2665-9913(22)00183-7. Epub 2022 Jul 25. Lancet Rheumatol. 2022. PMID: 37936680 Free PMC article.
-
Connexin 37, 40, 43 and Pannexin 1 Expression in the Gastric Mucosa of Patients with Systemic Sclerosis.Biomedicines. 2023 Sep 7;11(9):2487. doi: 10.3390/biomedicines11092487. Biomedicines. 2023. PMID: 37760928 Free PMC article.
-
Causes of severe infections in patients with systemic sclerosis and associated factors.Turk J Med Sci. 2022 Dec;52(6):1881-1888. doi: 10.55730/1300-0144.5535. Epub 2022 Dec 21. Turk J Med Sci. 2022. PMID: 36945989 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
